These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 34071185)

  • 1. Clinical Management of COVID-19: A Review of Pharmacological Treatment Options.
    Heustess AM; Allard MA; Thompson DK; Fasinu PS
    Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34071185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Update on Current Therapeutic Drugs Treating COVID-19.
    Wu R; Wang L; Kuo HD; Shannar A; Peter R; Chou PJ; Li S; Hudlikar R; Liu X; Liu Z; Poiani GJ; Amorosa L; Brunetti L; Kong AN
    Curr Pharmacol Rep; 2020; 6(3):56-70. PubMed ID: 32395418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis.
    Meo SA; Zaidi SZA; Shang T; Zhang JY; Al-Khlaiwi T; Bukhari IA; Akram J; Klonoff DC
    J King Saud Univ Sci; 2020 Oct; 32(7):3159-3166. PubMed ID: 32921965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
    Indari O; Jakhmola S; Manivannan E; Jha HC
    Front Pharmacol; 2021; 12():632677. PubMed ID: 33762954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.
    Mia ME; Howlader M; Akter F; Hossain MM
    Clin Pathol; 2024; 17():2632010X241263054. PubMed ID: 39070952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review on Current Repurposing Drugs for the Treatment of COVID-19: Reality and Challenges.
    Hossen MS; Barek MA; Jahan N; Safiqul Islam M
    SN Compr Clin Med; 2020; 2(10):1777-1789. PubMed ID: 32904710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the efficacy of regen-cov, remdesivir, and favipiravir in reducing invasive mechanical ventilation need in hospitalized COVID-19 patients.
    Hegazy SK; Tharwat S; Hassan AH
    World J Clin Cases; 2023 Sep; 11(26):6105-6121. PubMed ID: 37731581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug repurposing in COVID-19: A review with past, present and future.
    Srivastava K; Singh MK
    Metabol Open; 2021 Dec; 12():100121. PubMed ID: 34462734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients.
    Hegazy SK; Tharwat S; Hassan AH
    Open Med (Wars); 2023; 18(1):20230768. PubMed ID: 37588660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19.
    Haddad F; Dokmak G; Karaman R
    Life (Basel); 2022 Nov; 12(11):. PubMed ID: 36362912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
    Santos J; Brierley S; Gandhi MJ; Cohen MA; Moschella PC; Declan ABL
    Viruses; 2020 Jun; 12(7):. PubMed ID: 32629804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021.
    Alam S; Kamal TB; Sarker MMR; Zhou JR; Rahman SMA; Mohamed IN
    Front Pharmacol; 2021; 12():659577. PubMed ID: 34220503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical study to compare the efficacy and safety of casirivimab & imdevimab, remdesivir, and favipravir in hospitalized COVID-19 patients.
    Hegazy SK; Tharwat S; Hassan AH
    J Clin Virol Plus; 2023 Jun; 3(2):100151. PubMed ID: 37220480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Narrative Review of Antiviral Drugs Used for COVID-19 Pharmacotherapy.
    Kumar S; Saurabh MK; Maharshi V; Saikia D
    J Pharm Bioallied Sci; 2021; 13(2):163-171. PubMed ID: 34349475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Present and future treatment strategies for coronavirus disease 2019.
    Elekhnawy E; Kamar AA; Sonbol F
    Futur J Pharm Sci; 2021; 7(1):84. PubMed ID: 33850936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review.
    Wadaa-Allah A; Emhamed MS; Sadeq MA; Ben Hadj Dahman N; Ullah I; Farrag NS; Negida A
    Ann Med; 2021 Dec; 53(1):318-334. PubMed ID: 33706639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covid-19 scientific publications from Turkey.
    Çiftçiler R; Haznedaroğlu İC; Tufan A; Öztürk MA
    Turk J Med Sci; 2021 Jun; 51(3):. PubMed ID: 33306333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scoping insight on antiviral drugs against COVID-19.
    Ali AS; Ibrahim IM; Burzangi AS; Ghoneim RH; Aljohani HS; Alsamhan HA; Barakat J
    Arab J Chem; 2021 Oct; 14(10):103385. PubMed ID: 34909060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral therapy for COVID-19 virus: A narrative review and bibliometric analysis.
    Mawazi SM; Fathima N; Mahmood S; Al-Mahmood SMA
    Am J Emerg Med; 2024 Nov; 85():98-107. PubMed ID: 39244809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.